R1 Announces Agreement to Acquire VisitPay, the Leading Provider of Patient Financial Engagement Solutions
Enhanced R1 technology solution to provide digital patient payment and billing experience across all settings of care
May 04, 2021 06:35 ET | Source: R1 RCM Inc. R1 RCM Inc. Chicago, Illinois, UNITED STATES
CHICAGO, May 04, 2021 (GLOBE NEWSWIRE) R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced a definitive agreement to acquire VisitPay, the leading digital payment solution provider for approximately $300 million in cash.
VisitPay’s cloud-based platform is used by the nation’s largest and most innovative health systems to transform the payment experience and drive both improved patient satisfaction and higher collection yield. VisitPay’s best-in-class enterprise platform gives healthc
Message :
Required fields
CHICAGO, March 09, 2021 (GLOBE NEWSWIRE) R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced its management team will present at the KeyBanc Life Sciences & MedTech Investor Forum on Tuesday, March 23 at 10:45am ET.
A live audio webcast of the presentation will be available on the Investor Relations section of R1’s website at r1rcm.com. A replay of the webcast will be available for 90 days following the live webcast.
About R1 RCM
R1 is a leading provider of technology-driven solutions that transform the patient experience and financial performance of hospitals, health systems, and medical groups. R1’s proven and scalable operating models seamlessly complement a healthcare organization’s infrastructure, quickly driving sustainable improvements to net patient revenue and cash flows while reducing operating costs and
DarioHealth Announces Participation in Stephens Virtual Best Ideas Conference
USA - English
Share this article
Share this article
NEW YORK, March 5, 2021 /PRNewswire/ DarioHealth Corp. (NASDAQ: DRIO), a pioneer in the global digital therapeutics (DTx) market, announced today that the company will participate in the upcoming Stephens 2021 Best Ideas Conference on March 11, 2021.
Dario s CEO, Erez Raphael, and Rick Anderson, President and General Manager for North America, are scheduled to present in a virtual setting on Thursday, March 11th, 2021 at 9:00 a.m. ET. A live webcast and replay of the presentation will be available at https://kvgo.com/stephens-best-ideas-conference/dario-health-march-2021.
About DarioHealth Corp.
DarioHealth Study Examines Connection Between Personalization and Sustained Behavior Change in Digital Health
USA - English
News provided by
Share this article
Share this article
NEW YORK, March 2, 2021 /PRNewswire/ DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics (DTx) market, today announced the results of a new clinical study that have been published in the
Journal of Medical Internet Research (JMIR) Diabetes. The paper is titled Role of Digital Engagement in Diabetes Care Beyond Measurement: Retrospective Cohort Study.
In the world of digital health, the focus has long been the differences between people - analyzing data, patterns, and demographics to create personas that match like individuals. The idea behind many current digital health solutions is that personalization is your fingerprint , but while fingerprints don t change, people do. What an individual liked and was willing to try yesterday may not be what they are willing to